Brief: Translate Bio Reports Q2 2021 Financial Results
05/08/2021 23:37
Aug 5 (Reuters) - Translate Bio Inc TBIO.O :
* TRANSLATE BIO ANNOUNCES SECOND QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* TRANSLATE BIO INC - COLLABORATION REVENUE WAS $72.6
MILLION AND
$16.3 MILLION FOR THE THREE MONTHS ENDED JUNE 30, 2021 AND 2020,
RESPECTIVELY
Source text for Eikon: ID:nGNX7tRvlV
Further company coverage: TBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telesis Bio
See all newsBrief: Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview